Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Traditional Chinese medicine prescription for treating myasthenia gravis

A technology of myasthenia gravis and traditional Chinese medicine, which is applied in the direction of medical formula, medical raw materials derived from gymnosperms, drug combinations, etc., can solve the problems of treating the symptoms but not the root cause, and the long-term application of single drugs, etc., to achieve good curative effect and the source of raw materials Rich, low-cost effects

Active Publication Date: 2018-10-16
乞国艳
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Treatment: (1) Cholinesterase inhibitors are symptomatic drugs that treat the symptoms but not the root cause. They cannot be used as a single drug for a long time. The method of medication should be gradually increased from a small dose

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine prescription for treating myasthenia gravis
  • Traditional Chinese medicine prescription for treating myasthenia gravis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] The preparation of embodiment 1 Chinese medicine composition

[0044] 1. Accurately weigh the following Chinese medicine raw materials: 100 parts of astragalus, 30 parts of Codonopsis pilosula, 24 parts of Atractylodes macrocephala, 10 parts of Bupleurum, 10 parts of Cimicifuga, 10 parts of angelica, 6 parts of licorice, 6 parts of tangerine peel, 10 parts of wolfberry, cornus 12 parts, 12 parts of mulberry, 20 parts of yam, 30 parts of jujube seed, 15 parts of Baiziren, 15 parts of rehmannia glutinosa, 15 parts of raw land, 24 parts of salvia, 15 parts of schisandra, and 12 parts of privet fruit.

[0045] 2. The above raw materials were crushed into coarse powder, decocted twice with 10 times the volume of water, each time for 2 hours, and the extracts were combined; concentrated under reduced pressure to obtain the traditional Chinese medicine composition.

Embodiment 2

[0046] The preparation of embodiment 2 Chinese medicine composition

[0047] 1. Accurately weigh the following traditional Chinese medicine raw materials: 50 parts of astragalus, 20 parts of Codonopsis, 15 parts of Atractylodes macrocephala, 8 parts of Bupleurum, 8 parts of Cimicifuga, 8 parts of angelica, 5 parts of licorice, 4 parts of tangerine peel, 8 parts of wolfberry, and cornus 10 parts, 8 parts of mulberry, 12 parts of yam, 20 parts of jujube seed, 10 parts of Baiziren, 12 parts of rehmannia glutinosa, 12 parts of raw land, 15 parts of salvia miltiorrhiza, 15 parts of Schisandra chinensis, and 10 parts of Ligustrum lucidum.

[0048] 2. The above raw materials were crushed into coarse powder, decocted twice with 9 times the volume of water, each time for 2 hours, and the extracts were combined; concentrated under reduced pressure to obtain the traditional Chinese medicine composition.

Embodiment 3

[0049] The preparation of embodiment 3 Chinese medicine composition

[0050] 1. Accurately weigh the following traditional Chinese medicine raw materials: 10 parts of astragalus, 10 parts of Codonopsis, 10 parts of Atractylodes macrocephala, 5 parts of Bupleurum, 5 parts of Cimicifuga, 5 parts of angelica, 3 parts of licorice, 3 parts of tangerine peel, 5 parts of wolfberry, and cornus 9 parts, 5 parts of mulberry, 5 parts of yam, 15 parts of jujube seed, 6 parts of Baiziren, 10 parts of rehmannia glutinosa, 10 parts of raw land, 6 parts of salvia miltiorrhiza, 15 parts of Schisandra chinensis, and 6 parts of Ligustrum lucidum.

[0051] 2. The above raw materials were crushed into coarse powder, decocted twice with 8 times the volume of water, each time for 2 hours, and the extracts were combined; concentrated under reduced pressure to obtain the traditional Chinese medicine composition.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a traditional Chinese medicine composition for treating myasthenia gravis. The traditional Chinese medicine composition is prepared from the following crude drugs in parts by weight: 10-100 parts of radix astragali seu hedysari, 10-30 parts of radix codonopsis, 10-24 parts of bighead atractylodes rhizome, 5-10 parts of radix bupleuri, 5-10 parts of cimicifugae rhizoma, 5-10parts of Chinese angelica, 3-6 parts of liquorice root, 3-6 parts of pericarpium citri reticulatae, 5-10 parts of fructus lycii, 9-12 parts of fructus corni, 5-12 parts of mulberry fruit, 5-20 partsof dioscoreae rhizoma, 15-30 parts of ziziphi spinosae semen, 6-15 parts of platycladi seed, 10-15 parts of radix rehmanniae preparata, 10-15 parts of rehmannia root, 6-24 parts of radix salviae miltiorrhizae, 15 parts of schisandrae chinensis fructus and 6-12 parts of fructus ligustri lucidi. According to the traditional Chinese medicine composition, through reasonable proportioning of the traditional Chinese medicine raw materials, by means of the synergistic effect among the components, the traditional Chinese medicine composition has good efficacy of treating myasthenia gravis.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine treatment and relates to a traditional Chinese medicine composition for treating myasthenia gravis. Background technique [0002] Myasthenia gravis (MG) is an autoimmune disease caused by dysfunction of the nerve-muscle junction. The main clinical manifestations are partial or general skeletal muscle weakness and easy fatigue. The symptoms are aggravated after activities and relieved after rest. . The prevalence rate is 77-150 / 1 million, and the annual incidence rate is 4-11 / 1 million. The prevalence rate of women is higher than that of men, about 3:2. All age groups have the disease, and most children are 1 to 5 years old. [0003] The causes of myasthenia gravis are divided into two categories, one is congenital hereditary, which is extremely rare and has nothing to do with autoimmunity; the second is autoimmune disease, which is the most common. The cause of the disease is not yet...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8945A61P21/04
CPCA61K36/14A61K36/232A61K36/233A61K36/284A61K36/344A61K36/40A61K36/481A61K36/484A61K36/537A61K36/57A61K36/605A61K36/638A61K36/71A61K36/725A61K36/752A61K36/79A61K36/804A61K36/815A61K36/8945A61K2236/331A61K2236/333A61K2236/39A61P21/04A61K2300/00
Inventor 乞国艳
Owner 乞国艳
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com